Drug Database
Back to search

Belgium· BE-AMP-SAM065414-00

Erythrocine IV 1 g

A erythromycin product containing erythromycin lactobionate, registered in Belgium by Amdipharm. The same ATC class is registered in 13 of our 19 countries.

ATC J01FA01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedErythrocine IV 1 gATCJ01FA01REGISTER NO.BE-AMP-SAM065414-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about erythromycin lactobionateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Erythromycin is registered in 13 of 19 countries.

Countries holding a registration under ATC J01FA01 (erythromycin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search erythromycin products by name

Erythromycin · ATC J01FA01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Erythromycin Lactobionate
Manufacturer
Amdipharm
Country
Belgium (BE)
ATC code
J01FA01
ATC class
Erythromycin
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0039834
  • be_apb
    0706507

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1011 interactions on record for erythromycin.

Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check erythromycin against other medicinesHow interaction checks work

Erythromycin · interactions on record

1011 records

  • 216 severe
  • 424 moderate
  • 70 minor
  • 227 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erythromycin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erythromycin products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Erythrocin - Lactobionat
  • Cyprus · Erythromycin I.V. Inresa
  • Germany · Erythrocin-I.V., Erythromycin Inresa
  • Spain · Pantomicina
  • France · Erythrocine
  • United Kingdom (Northern Ireland) · Erythrocin I.V. Lactobionate, Erythromycin Lactobionate Amdipharm Uk
  • Ireland · Erythrocin Iv Lactobionate
  • Italy · Eritromicina Lattobionato Fisiopharma
  • Norway · Abboticin
  • Portugal · Eritrocel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5cc76992-2d4e-4490-8e17-587965255c02
GET /v1/drugs/5cc76992-2d4e-4490-8e17-587965255c02?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Erythrocine IV 1 g",
  "name_fr": "Erythrocine IV 1 g",
  "name_nl": "Erythrocine IV 1 g",
  "amp_code": "SAM065414-00",
  "strengths": [
    "1.0000",
    "1.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Erythromycin Lactobionate",
    "Erythromycin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Erythromycin",
  "authorisation_numbers": [
    "BE065414"
  ]
}
API referenceMCP serverPlans

See everything about erythromycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console